Symbiont

blockchain

FOUNDING YEAR: 2013
LOCATION: United States
Last Update: 19/01/2021

Subscribe to the MEDICI Inner Circle Membership and gain access to an exclusive WhatsApp community where you can engage in discussions with global industry experts!

About

Symbiont has developed the market-leading platform for institutional applications of blockchain technology. Symbiont smart contracts enable complex instruments to live their entire lifecycle on a truly decentralized, enterprise blockchain network with end-to-end privacy. Institutions are working with Symbiont to develop new business lines, increase transparency, reduce risk, and save costs. Industry leaders such as IPREO, Ranieri and Vanguard have chosen to partner with Symbiont. Headquartered in New York City, Symbiont is a financial technology company founded by a team of experts in capital markets and blockchain technology.

MEDICI Analysis

Symbiont was formed as a combination of MathMoney (fx) and Counterparty. It is building a trading & issuance platform – ‘Smart Securities’ (self-executing digital contracts), utilizing the blockchain technology. They issued their first Smart Securities in Aug 2015 with initial use cases – corporate debt, syndicated loans, securitized instruments & private equity.

Focus

PRODUCTS & SERVICES

Decentralid trading

MAIN CLIENTS

Asset managers

Banks and Government

Traction

VALUATION / MARKET CAP:

$46.67 M in 2017

COMPANY TYPE:

For Profit

company provided insights
Web Traffic

Web Traffic

MONTHLY VISITS

13,005

AVERAGE VISITS (6 MONTHS)

4,271.55

MONTHLY VISITS GROWTH

434.59%

VISIT DURATION

13

VISIT DURATION GROWTH

-90.89%

PAGE VIEWS VISIT

1.18

PAGE VIEWS VISIT GROWTH

-11.53%

BOUNCE RATE

86.96%

BOUNCE RATE GROWTH

13.55%

GLOBAL TRAFFIC RANK

1,516,448

MONTHLY RANK CHANGE

-4,581,011

MONTHLY RANK GROWTH

-75.13%

Join the exclusive global FinTech community

Be a part of the global FinTech community on WhatsApp